Gary S. Hogge - SVP,Clinical & Medical Affairs at Lineage Cell Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP,Clinical & Medical Affairs
Issuer Symbol
LCTX on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Gary S. Hogge since 10 Feb 2025

Holdings reported by Gary S. Hogge for Lineage Cell Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares, no par value 7,710 $8,404 $1.09 11 Feb 2023 Direct
Employee Stock Option (right to buy) 400,000 09 Mar 2023 Direct Common Shares
Restricted Stock Units 39,061 11 Feb 2023 Direct Common Shares

Transactions reported by Gary S. Hogge for Lineage Cell Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.